Clinical Trials Directory

Trials / Conditions / Recurrent Primary Mediastinal Large B-Cell Lymphoma

Recurrent Primary Mediastinal Large B-Cell Lymphoma

8 registered clinical trials studyying Recurrent Primary Mediastinal Large B-Cell Lymphoma — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEpcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell T
NCT07365306
City of Hope Medical CenterPhase 2
RecruitingST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lym
NCT07098364
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
RecruitingOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
NCT06784726
University of WashingtonPhase 2
RecruitingGolcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphom
NCT06834373
Mayo ClinicPhase 2
RecruitingEpcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
NCT06536049
Yazeed SawalhaPhase 1 / Phase 2
Active Not RecruitingNKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymph
NCT05359211
Fred Hutchinson Cancer CenterPhase 1
CompletedCopanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell
NCT03484819
National Cancer Institute (NCI)Phase 2
Active Not RecruitingNivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho
NCT03038672
National Cancer Institute (NCI)Phase 2